azomycin has been researched along with Lymphoproliferative Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Branco, JN; Buffolo, E; Gaia, DF; Guilhen, JC; Palma, JH; Teles, A; Teles, CA | 1 |
| Bellotti, G; Bocchi, EA; Fiorelli, A; Higuchi, ML; Jatene, A; Pileggi, F; Stolf, N; Uip, D; Vieira, ML | 1 |
2 other study(ies) available for azomycin and Lymphoproliferative Disorders
| Article | Year |
|---|---|
Post-transplant lymphoproliferative disease presenting as a mass in the left ventricle in a heart transplant recipient at long-term follow-up.
Topics: Chagas Cardiomyopathy; Electrocardiography; Fatal Outcome; Follow-Up Studies; Heart Neoplasms; Heart Transplantation; Heart Ventricles; Humans; Immunosuppressive Agents; Lymphoproliferative Disorders; Magnetic Resonance Spectroscopy; Male; Middle Aged; Nitroimidazoles; Postoperative Complications; Recurrence; Time Factors; Ultrasonography | 2009 |
Higher incidence of malignant neoplasms after heart transplantation for treatment of chronic Chagas' heart disease.
Topics: Adult; Carcinoma, Squamous Cell; Chagas Cardiomyopathy; Chemoprevention; Chronic Disease; Cocarcinogenesis; Cyclosporine; Female; Follow-Up Studies; Heart Failure; Heart Transplantation; Humans; Immunosuppressive Agents; Incidence; Lung Diseases; Lymphoproliferative Disorders; Male; Mutagens; Neoplasms; Neurilemmoma; Nitroimidazoles; Recurrence; Sarcoma, Kaposi; Skin Neoplasms; Survival Rate; Trypanocidal Agents | 1998 |